EyeGene (XKRX:185490) Valuation Rank

View and export this data going back to 2015. Start your Free Trial

What is EyeGene Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

EyeGene Valuation Rank Related Terms

Thank you for viewing the detailed overview of EyeGene's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

EyeGene Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EyeGene Inc (XKRX:185490) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

Gangseo-gu, Seoul 401, B-dong 910 Gayang-dong, Seoul, KOR, 07528

Website

http://www.eyegene.co.kr

EyeGene Inc is a South Korea based bio-venture company. It researches and develops biopharmaceuticals. Its products include EG-Mirotin, EG-HPV, EGVac systems. It provides drugs for the treatment of age-related degenerative diseases. Its products target diabetic retinopathy.